Estriol (Dinotilis)
Estriol
Austell Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Austell Pharmaceuticals (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dinotilis EACH PESSARY CONTAINS ESTIROL 0,03 mg | Not listed | 56100656/18.6/1006 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Estriol
- when intended for hormone replacement therapy
- when intended for veterinary use
- except when intended for oral contraception; (S3)
- except when intended for human vaginal use (S2);
Consolidated Schedules 06 July 2026, lines 6255 to 6263
S3: Estriol
- when intended for oral contraception
- except when intended for human vaginal use (S2);
- except when intended for hormone replacement therapy. (S4)
- except when intended for veterinary use (S4)
Consolidated Schedules 06 July 2026, lines 3526 to 3534
S2: Estriol
- When intended for human vaginal use
- except when intended for oral contraception; (S3)
- except when intended for hormone replacement therapy; (S4)
- except when intended for veterinary use. (S4)
Consolidated Schedules 06 July 2026, lines 1935 to 1943
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(8R,9S,13S,14S,16R,17R)-13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
Drag to rotate. Structure from PubChem CID 5756.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.